Enveric Biosciences, Inc. (ENVB)

NASDAQ: ENVB · IEX Real-Time Price · USD

0.470

-0.019 (-3.87%)

At close: Jul 19, 2024, 4:00 PM

0.475

+0.005 (1.06%)

Pre-market: Jul 22, 2024, 7:35 AM EDT

Enveric Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2014
Selling, General & Admin	8.03	8.85	11.61	20.5	5.32	2.3	Upgrade
Research & Development	5.69	7.25	8.03	4.79	0.17	0	Upgrade
Other Operating Expenses	0.34	0.34	7.78	39.34	0.12	0	Upgrade
Operating Expenses	14.07	16.45	27.42	64.62	5.62	2.3	Upgrade
Operating Income	-14.07	-16.45	-27.42	-64.62	-5.62	-2.3	Upgrade
Interest Expense / Income	-0	-0	0.01	0.01	0.45	0.08	Upgrade
Other Expense / Income	0.98	0.82	-7.46	-8.2	0.8	0.03	Upgrade
Pretax Income	-15.04	-17.26	-19.96	-56.43	-6.86	-2.41	Upgrade
Income Tax	0.03	0.03	-1.49	-7.45	0	0	Upgrade
Net Income	-15.07	-17.29	-18.47	-48.98	-6.86	-2.41	Upgrade
Preferred Dividends	0.04	0.17	0.33	0	0	0	Upgrade
Net Income Common	-15.11	-17.46	-18.8	-48.98	-6.86	-2.41	Upgrade
Shares Outstanding (Basic)	4	2	1	0	0	0	Upgrade
Shares Outstanding (Diluted)	4	2	1	0	0	0	Upgrade
Shares Change	92.54%	49.31%	206.13%	310.48%	8.82%	2122.43%	Upgrade
EPS (Basic)	-6.42	-8.09	-13.00	-103.69	-59.50	-23.00	Upgrade
EPS (Diluted)	-6.42	-8.09	-13.00	-103.69	-59.50	-23.00	Upgrade
Free Cash Flow	-11.54	-14.08	-17.73	-11.65	-3.89	-0.65	Upgrade
Free Cash Flow Per Share	-2.88	-6.52	-12.26	-24.66	-33.79	-6.13	Upgrade
EBITDA	-14.66	-16.86	-19.52	-55.74	-6.3	-2.33	Upgrade
Depreciation & Amortization	0.38	0.41	0.44	0.68	0.12	0	Upgrade
EBIT	-15.04	-17.27	-19.95	-56.42	-6.42	-2.33	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).